Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1977;70(Suppl 10):5–14. doi: 10.1177/0035915777070S1002

Behavioural Characterization of Neuroleptic Properties in the Rodent

B Costall, R J Naylor
PMCID: PMC1542821  PMID: 20919320

Full text

PDF
5

Images in this article

5p5-a
on p.5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartholini G., Haefely W., Jalfre M., Keller H. H., Pletscher A. Effects of clozapine on cerebral catecholaminergic neurone systems. Br J Pharmacol. 1972 Dec;46(4):736–740. doi: 10.1111/j.1476-5381.1972.tb06898.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berger B., Thierry A. M., Tassin J. P., Moyne M. A. Dopaminergic innervation of the rat prefrontal cortex: a fluorescence histochemical study. Brain Res. 1976 Apr 16;106(1):133–145. doi: 10.1016/0006-8993(76)90078-0. [DOI] [PubMed] [Google Scholar]
  3. Borenstein P., Bles G. Effets cliniques et électroencéphalographiques du métoclopramide en psychiatrie. Therapie. 1965 Jul-Aug;20(4):975–995. [PubMed] [Google Scholar]
  4. Cools A. R., Hendriks G., Korten J. The acetylcholine-dopamine balance in the basal ganglia of rhesus monkeys and its role in dynamic, dystonic, dyskinetic, and epileptoid motor activities. J Neural Transm. 1975;36(2):91–105. doi: 10.1007/BF01256757. [DOI] [PubMed] [Google Scholar]
  5. Costall B., Naylor R. J. Neuroleptic and non-neuroleptic catalepsy. Arzneimittelforschung. 1973 May;23(5):674–683. [PubMed] [Google Scholar]
  6. Costall B., Naylor R. J., Owen R. T. Investigations into the nature of the peri-oral movements induced by 2-(N-N-dipropyl) amino-5,6-dihydroxytetralin. Eur J Pharmacol. 1977 Oct 15;45(4):357–367. doi: 10.1016/0014-2999(77)90275-8. [DOI] [PubMed] [Google Scholar]
  7. Costall B., Naylor R. J., Pinder R. M. Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig. Eur J Pharmacol. 1975 Mar;31(1):94–109. doi: 10.1016/0014-2999(75)90082-5. [DOI] [PubMed] [Google Scholar]
  8. Haase H. J., Floru L., Ulrich F. Klinisch-neuroleptische Untersuchung des N-((1-Athyl-pyrrolidin-2-yl)-methyl)-2-methoxy-5-sulfamoyl-Benzamid-Neuroleptikums Sulpirid (Dogmatil) an akut erkrankten Schizophrenen. Int Pharmacopsychiatry. 1974;9(2):77–94. [PubMed] [Google Scholar]
  9. Janssen P. A., Niemegeers C. J., Schellekens K. H., Lenaerts F. M. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats. Arzneimittelforschung. 1967 Jul;17(7):841–854. [PubMed] [Google Scholar]
  10. Korczyn A. D. Pathophysiology of drug-induced dyskinesias. Neuropharmacology. 1972 Sep;11(5):601–607. doi: 10.1016/0028-3908(72)90068-8. [DOI] [PubMed] [Google Scholar]
  11. Laville C., Margarit J. Influence du sulpiride sur l'activité et la vigilance cez la souris. Pathol Biol. 1968 Jun-Jul;16(11):663–665. [PubMed] [Google Scholar]
  12. Miller R. J., Hiley C. R. Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism. Nature. 1974 Apr 12;248(449):596–597. doi: 10.1038/248596a0. [DOI] [PubMed] [Google Scholar]
  13. Muller P., Seeman P. Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system. J Pharm Pharmacol. 1974 Dec;26(12):981–984. doi: 10.1111/j.2042-7158.1974.tb09222.x. [DOI] [PubMed] [Google Scholar]
  14. Puech A. J., Simon P., Boissier J. R. Antagonism by sulpiride of three apomorphine-induced effects in rodents. Eur J Pharmacol. 1976 Apr;36(2):439–441. doi: 10.1016/0014-2999(76)90098-4. [DOI] [PubMed] [Google Scholar]
  15. Sayers A. C., Kleinlogel H. Neuropharmakologische Befunde unter chronischer Verabreichung von Haloperidol, Loxapin und Clozapin. Arzneimittelforschung. 1974 Jul;24(7):981–983. [PubMed] [Google Scholar]
  16. Simon H., Le Moal M., Galey D., Cardo B. Silver impregnation of dopaminergic systems after radiofrequency and 6-OHDA lesions of the rat ventral. Brain Res. 1976 Oct 15;115(2):215–231. doi: 10.1016/0006-8993(76)90508-4. [DOI] [PubMed] [Google Scholar]
  17. Snyder S., Greenberg D., Yamamura H. I. Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects. Arch Gen Psychiatry. 1974 Jul;31(1):58–61. doi: 10.1001/archpsyc.1974.01760130040006. [DOI] [PubMed] [Google Scholar]
  18. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl. 1971;367:1–48. doi: 10.1111/j.1365-201x.1971.tb10998.x. [DOI] [PubMed] [Google Scholar]
  19. Versteeg D. H., Van Der Gugten J., De Jong W., Palkovits M. Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res. 1976 Sep 3;113(3):563–574. doi: 10.1016/0006-8993(76)90057-3. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES